GlycoMimetics Reports First Quarter 2019 Results and Recent Operational Highlights

07:00 EDT 2 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Enrolled first patient in National Cancer Institute (NCI)-sponsored Phase 3 trial of uproleselan in older adults with previously untreated acute myeloid leukemia (AML) Announced plans to initiate a tr...

Other Sources for this Article

Investor Contact:
Shari Annes
Phone: 650-888-0902

Media Contact:
Jamie Lacey-Moreira
Phone: 410-299-3310


More From BioPortfolio on "GlycoMimetics Reports First Quarter 2019 Results and Recent Operational Highlights"

Quick Search

Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Leukemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader grou...